Drugs / Cellular therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02108132 | Aug 2014 → Aug 2015 | hemophilia | Cairo University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cellular therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02108132 ↗ |
| Modality | Cell therapy | “The hypothesis of the present study is to use allogenic bone marrow derived mesenchymal stem cells induced to adopt hepatocyte phenotype in vitro as a cellular therapy product...” NCT02108132 ↗ |
| Route | Other | “injected through the portal vein” NCT02108132 ↗ |